Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND):
Earnings: -$17.49 million in Q4 vs. -$5.42 million in the same period last year.
EPS: -$1.04 in Q4 vs. -$0.32 in the same period last year.
Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $23.53 million or $1.36 per share for the period.
Revenue: $50.38 million in Q4 vs. $56.40 million in the same period last year.
For comments and feedback contact: editorial@rttnews.com